n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine has been researched along with 2,5-dimethoxy-4-ethylthiophenethylamine in 1 studies
Studies (n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine) | Trials (n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine) | Recent Studies (post-2010) (n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine) | Studies (2,5-dimethoxy-4-ethylthiophenethylamine) | Trials (2,5-dimethoxy-4-ethylthiophenethylamine) | Recent Studies (post-2010) (2,5-dimethoxy-4-ethylthiophenethylamine) |
---|---|---|---|---|---|
37 | 1 | 1 | 6 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clare, BW | 1 |
1 other study(ies) available for n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine and 2,5-dimethoxy-4-ethylthiophenethylamine
Article | Year |
---|---|
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory | 1998 |